Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 3,625-3,636 of 5,650
Drug study icon
RecruitingNCT06636357

Nitrous Oxide in the Treatment of Acute Suicide prevention

This summary needs review. Please check the official study record and contact the research team for details.

In Zurich
SuicidalityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Switzerland
Sponsor
University of Zurich
Condition
Suicidality
Drug study icon
RecruitingNCT05136755

NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder

This study is looking at examine the efficacy and safety of an NMDA enhancer (NMDAE) in the treatment of antidepressant nonresponders with depression for people with depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In Taichung
DepressionDrugFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Depression
Drug study icon
RecruitingNCT04637620

NMDA Modulation in Major Depressive Disorder

This study is comparing NMDAE with placebo for people with depression. Participants receive NMDAE or placebo and complete study visits and assessments.

In Taichung
DepressionDrugFrom 18 Years to 55 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Depression
Drug study icon
RecruitingNCT02994433

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

In St Louis
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Depression
Drug study icon
RecruitingNCT05977023

NMDA Receptor Modulation for Bipolarity type I

This study is looking at care and outcomes for people with Bipolarity I. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In Taichung
BipolarityDrugFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Bipolarity
Drug study icon
RecruitingNCT06021197

NMDA-enhancing Treatment for Cognitive Dysfunction of Schizophrenia

This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

In Taichung
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT07606014

No Guts No Glory Probiotics

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Leeuwarden
SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Netherlands
Sponsor
University Medical Center Groningen
Condition
Schizophrenia
Other study type icon
RecruitingNCT07383467

No Time to Wait: Single Session Intervention

This study is looking at whether a digital support tool can help people with Depression - depression or Anxiety. Participants take part in a digital support tool and complete follow-up assessments.

In Hong Kong
Depression, AnxietyOtherFrom 12 Years to 17 Years
Countries
China
Sponsor
United Christian Hospital
Condition
Depression, Anxiety
Behavioral study icon
RecruitingNCT06417437

Non-invasive BCI and Application Verification for Depressed People

This study is looking at whether a digital support tool can help people with Depression or Depression in bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In Shanghai
Depression, BipolarityBehavioralOver 12 Years
Countries
China
Sponsor
Shanghai Mental Health Center
Condition
Depression, Bipolarity
Behavioral study icon
RecruitingNCT07469384

Non-invasive Brain Stimulation Using Tdcs of the Third (of Many) Visual Pathways

This study is looking at whether a digital support tool can help people with SCHIZOPHRENIA 1 or Schizo Affective Disorder. Participants take part in a digital support tool and complete follow-up assessments.

In Orangeburg
SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.